CRLX301: Phase I/IIa started

Cerulean began an open-label, international Phase I/IIa trial to

Read the full 90 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE